Palvella Therapeutics, Inc. (PVLA)
150.68
-3.64
(-2.36%)
USD |
NASDAQ |
Sep 18, 16:00
150.68
0.00 (0.00%)
After-Hours: 20:00
Palvella Therapeutics Total Liabilities (Quarterly) : 36.64M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 36.64M |
| March 31, 2026 | 31.45M |
| December 31, 2025 | 31.58M |
| September 30, 2025 | 28.26M |
| June 30, 2025 | 25.97M |
| March 31, 2025 | 23.86M |
| September 30, 2024 | 4.254M |
| June 30, 2024 | 6.346M |
| March 31, 2024 | 7.533M |
| December 31, 2023 | 11.92M |
| September 30, 2023 | 28.87M |
| June 30, 2023 | 47.05M |
| March 31, 2023 | 66.80M |
| December 31, 2022 | 67.56M |
| September 30, 2022 | 63.40M |
| June 30, 2022 | 69.94M |
| March 31, 2022 | 83.66M |
| December 31, 2021 | 102.80M |
| September 30, 2021 | 110.33M |
| June 30, 2021 | 108.31M |
| March 31, 2021 | 77.55M |
| December 31, 2020 | 73.98M |
| September 30, 2020 | 72.03M |
| June 30, 2020 | 71.11M |
| March 31, 2020 | 73.97M |
| Date | Value |
|---|---|
| December 31, 2019 | 89.74M |
| September 30, 2019 | 96.11M |
| June 30, 2019 | 111.36M |
| March 31, 2019 | 100.89M |
| December 31, 2018 | 101.41M |
| September 30, 2018 | 101.40M |
| June 30, 2018 | 106.71M |
| March 31, 2018 | 122.55M |
| December 31, 2017 | 92.35M |
| September 30, 2017 | 94.30M |
| June 30, 2017 | 96.62M |
| March 31, 2017 | 43.84M |
| December 31, 2016 | 9.836M |
| September 30, 2016 | 12.23M |
| June 30, 2016 | 9.163M |
| March 31, 2016 | 10.03M |
| December 31, 2015 | 2.822M |
| September 30, 2015 | 2.550M |
| June 30, 2015 | 3.330M |
| March 31, 2015 | 2.547M |
| December 31, 2014 | 3.878M |
| September 30, 2014 | 8.402M |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | 6.692M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Agenus, Inc. | 378.54M |
| Amgen, Inc. | 83.95B |
| Anika Therapeutics, Inc. | 46.19M |
| BioCryst Pharmaceuticals, Inc. | 1.012B |
| Imunon, Inc. | 10.80M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 253.51M |
| Shareholders Equity (Quarterly) | 216.87M |
| Debt to Equity Ratio | 0.1044 |
| Current Ratio | 21.18 |
| Net Debt Paydown Yield | -0.21% |